KIORA PHARMACEUTICALS, INC. (KPRX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
22/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinKPRX / S&P 36.27% / 15.20% |
LoseKPRX / S&P KPRX unavailable / 15.00% |
LoseKPRX / S&P -13.75% / 50.40% |
| 2026-Q11/3 |
WinKPRX / S&P -2.03% / -4.33% |
LoseKPRX / S&P KPRX unavailable / 11.30% |
LoseKPRX / S&P -6.55% / 27.70% |
| 2025-Q40/3 |
LoseKPRX / S&P -29.14% / 2.65% |
LoseKPRX / S&P -100.00% / 9.00% |
LoseKPRX / S&P -345.37% / 13.40% |
| 2025-Q30/3 |
LoseKPRX / S&P -3.47% / 8.12% |
LoseKPRX / S&P -100.00% / 4.61% |
LoseKPRX / S&P -271.31% / 13.45% |
| 2025-Q20/3 |
LoseKPRX / S&P -4.32% / 10.94% |
LoseKPRX / S&P -100.00% / 4.83% |
LoseKPRX / S&P -44.78% / 10.63% |
| 2025-Q10/3 |
LoseKPRX / S&P -8.79% / -4.27% |
LoseKPRX / S&P -99.88% / 4.98% |
LoseKPRX / S&P -75.61% / 10.57% |
| 2024-Q40/3 |
LoseKPRX / S&P -9.84% / 2.41% |
LoseKPRX / S&P KPRX unavailable / 5.25% |
LoseKPRX / S&P -106.61% / 6.15% |
| 2024-Q30/3 |
LoseKPRX / S&P -12.86% / 5.89% |
LoseKPRX / S&P KPRX unavailable / 5.89% |
LoseKPRX / S&P -110.22% / 6.11% |
| 2024-Q20/3 |
LoseKPRX / S&P -33.90% / 4.28% |
LoseKPRX / S&P KPRX unavailable / 5.38% |
LoseKPRX / S&P -50.61% / 5.12% |
| 2024-Q12/3 |
WinKPRX / S&P 35.25% / 10.56% |
LoseKPRX / S&P KPRX unavailable / 5.71% |
WinKPRX / S&P 221.35% / 5.59% |
| 2023-Q41/3 |
LoseKPRX / S&P -8.10% / 11.69% |
LoseKPRX / S&P KPRX unavailable / 6.81% |
WinKPRX / S&P 17.04% / 7.78% |
| 2023-Q30/3 |
LoseKPRX / S&P -11.66% / -3.27% |
LoseKPRX / S&P KPRX unavailable / 7.52% |
LoseKPRX / S&P -69.31% / -5.03% |
| 2023-Q20/3 |
LoseKPRX / S&P -80.75% / 8.74% |
LoseKPRX / S&P KPRX unavailable / 9.50% |
LoseKPRX / S&P -75.87% / -8.57% |
| 2023-Q10/3 |
LoseKPRX / S&P -2.62% / 7.50% |
LoseKPRX / S&P KPRX unavailable / 10.77% |
LoseKPRX / S&P -91.66% / -15.69% |
| 2022-Q40/3 |
LoseKPRX / S&P -44.23% / 7.56% |
LoseKPRX / S&P KPRX unavailable / 11.88% |
LoseKPRX / S&P -58.15% / -17.99% |
| 2022-Q31/3 |
LoseKPRX / S&P -67.36% / -4.88% |
LoseKPRX / S&P KPRX unavailable / 13.47% |
WinKPRX / S&P 212.03% / -1.41% |
| 2022-Q21/3 |
LoseKPRX / S&P -24.28% / -16.10% |
LoseKPRX / S&P KPRX unavailable / 13.71% |
WinKPRX / S&P 2716.56% / 11.04% |
| 2022-Q10/3 |
LoseKPRX / S&P -58.81% / -4.60% |
LoseKPRX / S&P KPRX unavailable / 15.97% |
LoseKPRX / S&P KPRX unavailable / 42.23% |
| 2021-Q40/3 |
LoseKPRX / S&P -32.89% / 11.03% |
LoseKPRX / S&P KPRX unavailable / 15.00% |
LoseKPRX / S&P KPRX unavailable / 96.40% |
| 2021-Q30/3 |
LoseKPRX / S&P -38.19% / 0.58% |
LoseKPRX / S&P KPRX unavailable / 10.77% |
LoseKPRX / S&P KPRX unavailable / 69.42% |
| 2021-Q20/3 |
LoseKPRX / S&P -26.91% / 8.55% |
LoseKPRX / S&P KPRX unavailable / 6.58% |
LoseKPRX / S&P KPRX unavailable / 51.81% |
| 2021-Q10/3 |
LoseKPRX / S&P 1.01% / 6.17% |
LoseKPRX / S&P KPRX unavailable / -1.06% |
LoseKPRX / S&P KPRX unavailable / 7.39% |
| 2020-Q41/3 |
WinKPRX / S&P 25.77% / 12.15% |
LoseKPRX / S&P -99.55% / -3.72% |
LoseKPRX / S&P KPRX unavailable / -33.42% |
| 2020-Q30/3 |
LoseKPRX / S&P -18.50% / 8.93% |
LoseKPRX / S&P -100.00% / -2.04% |
LoseKPRX / S&P KPRX unavailable / -27.10% |
| 2020-Q20/3 |
LoseKPRX / S&P -7.50% / 20.54% |
LoseKPRX / S&P -100.00% / -0.46% |
LoseKPRX / S&P KPRX unavailable / -27.11% |
| 2020-Q10/3 |
LoseKPRX / S&P -48.10% / -19.60% |
LoseKPRX / S&P -100.00% / 3.47% |
LoseKPRX / S&P KPRX unavailable / -14.75% |
| 2019-Q42/3 |
WinKPRX / S&P 214.11% / 9.07% |
WinKPRX / S&P 62.54% / 5.36% |
LoseKPRX / S&P KPRX unavailable / 2.99% |
| 2019-Q31/3 |
LoseKPRX / S&P -11.39% / 1.70% |
WinKPRX / S&P 62.54% / 5.02% |
LoseKPRX / S&P KPRX unavailable / 0.21% |
| 2019-Q21/3 |
LoseKPRX / S&P -21.31% / 4.30% |
WinKPRX / S&P 112.39% / 6.64% |
LoseKPRX / S&P KPRX unavailable / 8.65% |
| 2019-Q11/3 |
LoseKPRX / S&P -34.41% / 13.65% |
WinKPRX / S&P 145.83% / 8.12% |
LoseKPRX / S&P KPRX unavailable / 14.29% |
| 2018-Q42/3 |
WinKPRX / S&P 50.00% / -13.52% |
WinKPRX / S&P 305.51% / 9.05% |
LoseKPRX / S&P KPRX unavailable / 18.23% |
| 2018-Q31/3 |
LoseKPRX / S&P -41.51% / 7.71% |
WinKPRX / S&P 190.99% / 10.21% |
LoseKPRX / S&P KPRX unavailable / 19.06% |
| 2018-Q22/3 |
WinKPRX / S&P 39.47% / 3.43% |
WinKPRX / S&P 84.07% / 9.03% |
LoseKPRX / S&P KPRX unavailable / 14.46% |
| 2018-Q11/3 |
LoseKPRX / S&P -64.49% / -0.76% |
WinKPRX / S&P 54.49% / 7.68% |
LoseKPRX / S&P KPRX unavailable / 12.46% |
| 2017-Q40/3 |
LoseKPRX / S&P -8.55% / 6.64% |
LoseKPRX / S&P -39.11% / 7.03% |
LoseKPRX / S&P KPRX unavailable / 13.82% |
| 2017-Q31/3 |
LoseKPRX / S&P -14.60% / 4.48% |
WinKPRX / S&P 11.59% / 5.68% |
LoseKPRX / S&P KPRX unavailable / 17.57% |
| 2017-Q21/3 |
LoseKPRX / S&P -46.27% / 3.09% |
WinKPRX / S&P 227.14% / 4.83% |
LoseKPRX / S&P KPRX unavailable / 17.74% |
| 2017-Q11/3 |
WinKPRX / S&P 56.44% / 6.07% |
LoseKPRX / S&P KPRX unavailable / 3.67% |
LoseKPRX / S&P KPRX unavailable / 13.32% |
| 2016-Q40/3 |
LoseKPRX / S&P -5.23% / 3.82% |
LoseKPRX / S&P KPRX unavailable / 2.09% |
LoseKPRX / S&P KPRX unavailable / 7.05% |
| 2016-Q30/3 |
LoseKPRX / S&P -33.59% / 3.85% |
LoseKPRX / S&P KPRX unavailable / 0.20% |
LoseKPRX / S&P KPRX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | KPRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -4.32% | 20.78% |
| Annualized return | -4.32% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | KPRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.60% | 83.14% |
| Annualized return | -66.87% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | KPRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.97% | 319.30% |
| Annualized return | -55.92% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |